Home › Respiratory Tract Infections › South Carolina
Respiratory Tract Infections clinical trials in South Carolina
3 studies for Respiratory Tract Infections are looking for participants at sites in South Carolina.
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Greenville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Medical University of South Carolina Infectious Disease Clinic, Charleston
- Medical University of South Carolina Investigational Drug Services (IDS), Charleston
- Medical University of South Carolina Investigational Drug Services Pharmacy, Charleston
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Medical University of South Carolina Ashley River Tower, Charleston
- Medical University of South Carolina - SCTR Research Nexus, Charleston
- Medical University of South Carolina, Charleston
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.